Edap TMS SA (EDAP)
2.49
+0.04
(+1.63%)
USD |
NASDAQ |
Nov 21, 16:00
2.50
+0.01
(+0.40%)
Pre-Market: 20:00
Edap TMS Revenue (Quarterly): 14.41M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.41M |
| June 30, 2024 | 17.00M |
| March 31, 2024 | 16.19M |
| December 31, 2023 | 21.12M |
| September 30, 2023 | 12.78M |
| June 30, 2023 | 15.57M |
| March 31, 2023 | 15.89M |
| December 31, 2022 | 16.07M |
| September 30, 2022 | 12.33M |
| June 30, 2022 | 15.07M |
| March 31, 2022 | 14.59M |
| December 31, 2021 | 15.98M |
| September 30, 2021 | 11.13M |
| June 30, 2021 | 12.47M |
| March 31, 2021 | 12.41M |
| December 31, 2020 | 18.32M |
| September 30, 2020 | 11.03M |
| June 30, 2020 | 10.19M |
| March 31, 2020 | 8.398M |
| December 31, 2019 | 13.27M |
| September 30, 2019 | 11.46M |
| June 30, 2019 | 14.03M |
| March 31, 2019 | 11.51M |
| December 31, 2018 | 9.478M |
| September 30, 2018 | 30.11M |
| Date | Value |
|---|---|
| June 30, 2018 | 10.27M |
| March 31, 2018 | 11.25M |
| December 31, 2017 | 12.51M |
| September 30, 2017 | 8.376M |
| June 30, 2017 | 10.25M |
| March 31, 2017 | 9.241M |
| December 31, 2016 | 11.54M |
| September 30, 2016 | 8.920M |
| June 30, 2016 | 9.261M |
| March 31, 2016 | 9.628M |
| December 31, 2015 | 12.90M |
| September 30, 2015 | 7.120M |
| June 30, 2015 | 8.660M |
| March 31, 2015 | 7.015M |
| December 31, 2014 | 8.090M |
| September 30, 2014 | 9.159M |
| June 30, 2014 | 7.725M |
| March 31, 2014 | 10.64M |
| December 31, 2013 | 11.01M |
| September 30, 2013 | 7.374M |
| June 30, 2013 | 5.880M |
| March 31, 2013 | 7.824M |
| December 31, 2012 | 12.22M |
| September 30, 2012 | 7.098M |
| June 30, 2012 | 7.865M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.398M
Minimum
Mar 2020
21.12M
Maximum
Dec 2023
14.21M
Average
14.50M
Median
Revenue (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 16.20M |
| Genfit SA | 15.36M |
| Adaptimmune Therapeutics PLC | 40.90M |
| Akari Therapeutics PLC | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.038M |
| Total Expenses (Quarterly) | 20.82M |
| EPS Diluted (Quarterly) | -0.187 |
| Enterprise Value | 68.17M |
| Gross Profit Margin (Quarterly) | 39.35% |
| Profit Margin (Quarterly) | -48.85% |
| Earnings Yield | -25.28% |
| Normalized Earnings Yield | -23.64 |